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Copyright © 2010 JCBN Summary Superoxide anion is the first generated reactive oxygen species (ROS) after oxygen
enters living cells. It was once considered to be highly deleterious to cell functions and aging.
Therefore, antioxidants were suggested to prevent aging and degenerative diseases. However,
superoxide signaling has been shown in many physiological responses such as transcriptional
regulation, protein activation, bioenergy output, cell proliferation and apoptosis. The
uncoupling proteins (UCPs) are a family of mitochondrial anion-carrier proteins located in the
inner mitochondrial membrane and are considered to reduce the generation of superoxide
anion through the mitochondrial mild uncoupling. UCPs are important in prevention of
mitochondrial excessive generation of ROS, transfer of mitochondrial substrates, mito-
chondrial calcium uniport and regulation of thermogenesis. Superoxide anion and uncoupling
proteins are linked to Alzheimer’s disease in mitochondria. Simultaneous disorders of
superoxide and uncoupling proteins create the conditions for neuronal oxidative damages. On
the one hand, sustained oxidative damage causes neuronal apoptosis and eventually, accumu-
lated neuronal apoptosis, leading to exacerbations of Alzheimer’s disease. On the other hand,
our study has shown that UCP2 and UCP4 have important impact on mitochondrial calcium
concentration of nerve cells, suggesting that their abnormal expression may involve in the
pathogenesis of Alzheimer’s disease.
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Introduction
Supoxide anion (O2￿−) is the first free radical of all reactive
oxygen species (ROS) generated in  vivo. Mitochondrial
respiratory chain is one of the main places where O2￿− is
produced [1]. A large number of studies have shown that
O2￿− can initiate a variety of oxidative damage responses to
phospholipids, proteins and nucleic acids by generating
many kinds of oxygen free radicals, causing degenerative
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diseases and aging [2]. Recently, it is found that the un-
coupling proteins embedded in mitochondrial inner mem-
brane are important molecules for the regulation of O2￿−
generation and protecting cells from oxidative damage [3].
Meanwhile, there’s a growing body of evidence to suggest
that O2￿− has important physiological functions in vivo, not
only the culprit of cellular oxidative damage. It puts forward
a theoretical challenge to the traditional concept of treating
degenerative diseases and aging by using antioxidants to
remove superoxide. This review will focus on the physio-
logical functions of O2￿− and uncoupling proteins, and try to
discuss their roles in the pathogenesis of Alzheimer’s disease.
Physiological Functions of O2￿−
Contrary to the once prevalent concept that O2￿− is highly
deleterious to cell function and healthy aging, at present, an
important role of superoxide signaling has been discovered
in a variety of physiological responses such as transcrip-
tional activation, bioenergy output, cell proliferation, and
apoptosis [4].
Transcriptional activation
New developments of superoxide anion participation in
enzymatic phosphorylation/dephosphorylation reactions are
of particular interest. These processes are mainly related to
protein kinase cascade. Baas and Berk have found that O2￿−
activated mitogen-activated protein kinases (MAPK) in
vascular smooth muscle cells by a way different from H2O2
in 1995 [5]. Huang et al. suggested that the peroxisome pro-
liferator activated receptor-γ (PPAR-γ) agonists stimulation
of extracellular signal-related protein kinase (EPK) phos-
phorylation in murine myoblasts was mediated by O2￿− [6]. It
was found that mitochondrial superoxide modulated nuclear
cAMP-responsive element-binding protein (CREB) phos-
phorylation in hippocampal neurons [7]. The activity of the
important nuclear transcription factor NFκB is regulated by
O2￿− formation. NFκB is maintained in the cytosol in an
inactive form bound to the inhibitor IκBα. Following
plasma membrane superoxide and H2O2 formation, induced
by various cell effectors (e.g. cytokines, hormones), and
regulated by Ras 1 (G protein), a transduction protein phos-
phokinase acts to phosphorylate IκBα. This phosphorylation
results in dissociation of the complex, IκBα-P ubiquitination
and its destruction by the proteasome, and release of NFκB
to translocate to the nucleus and function as a major
transcription regulator [8]. Interestingly, recent evidence
appears to directly implicate Na+/H+ transporter 1 (NHE1),
which is strongly suggested as a key molecule in redox-
mediated cell fate decisions, as a downstream target of intra-
cellular ROS such that an increase in intracellular O2￿−
stimulates NHE1 promoter activity and gene expression [9].
Cell differentiation and proliferation
There is a growing literature on normally produced extra-
cellular effectors determining the intracellular redox state
of cells and consequently in some instances the course of
cellular self-propagation or differentiation. As shown by
Smith et al., an intracellular redox environment induced to
favour a more oxidized state by thyroid hormone or bone
morphogenic protein 4 leads to a differentiation of the
precursor cells into oligodendrocytes or astrocytes. On the
other hand, an intracellular redox environment induced to
favour a more reducing state by basic fibroblast growth
factor or platelet-derived growth factor promotes self-
propagation of the precursor cells [10].
A substantial body of data support the involvement of low
levels of O2￿− in proliferative signaling. Increased, nontoxic
O2￿− levels achieved by downregulation of SOD with anti-
sense oligonucleotides inhibited apoptosis, whereas over-
expression of SOD or inhibition of NAD(P)H oxidase led
to a decrease in O2￿− and increased susceptibility of cells
to undergo apoptosis [11]. Mild elevation in intracellular
O2￿− stimulates growth responses in a variety of cell types via
activation of early growth-related genes such as c-fos and
c-jun, alterations in the activities of protein kinases, oxida-
tive inactivation of phosphatases, and activation of tran-
scription factors [12, 13]. It seems that O2￿− can serve as a
growth signal in different cells via a rac/ras-NAD(P)H
oxidase-MAPK signaling pathway [13]. Oberley et  al.
showed that overexpression of the oncogenic form of the
small G protein v-Ha-ras increased O2￿− generation and the
growth of the human keratinocyte cell line HaCaT. In
contrast, overexpression of virally transduced SOD blocked
the growth-stimulatory effect of v-Ha-ras overexpression,
suggesting that intracellular O2￿− was responsible for this
effect. In addition to the keratinocyte cell line, rat kidney
epithelial cells could also be stimulated to grow and form
colonies in soft agar in an O2￿−-dependent manner by v-Ha-
ras overexpression [14].
A few studies also suggested the involvement of O2￿− in
differentiation signaling. Wang et al. have reported that O2￿−
can promote osteogenic differentiation of mesenchymal
stem cells using animal and cell models [15]. Lately, reduced
expression of the NADPH oxidase NOX4 was suggested as
a hallmark of adipocyte differentiation. Data suggest an
appealing scenario where in preadipocytes an initial insulin-
induced “burst” in superoxide production may trigger sig-
naling events leading to the initialization of the adipocyte
differentiation process and eventually to the downregulation
of NOX4 and the upregulation of insulin receptor expression
[16].
Immunoprotection
T cell activation during an immune response is strongly
augmented in the presence of O2￿− or at relatively lowSuperoxide, UCPs and Alzheimer’s Disease
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concentrations of H2O2 via ROS dependent increase in IL-2
promoter activity and transcription and surface expression of
the IL-2 receptor [17]. Macrophage plasma membrane
NADPH oxidase is a potent source of very high concentra-
tions of O2￿− and hydrogen peroxide (mM) employed for the
killing of sequestrated pathogen [18]. Moreover, recent find-
ings suggest that ROS generated from the NADPH oxidase
complex contribute to monocyte/macrophage survival [19].
Regulation of energy metabolism- Ca2+ regulating messenger
Wu and de Champlain have shown that superoxide
enhanced the hydrolysis of phosphatidylinositol (PIP) to
inositol 1,4,5-tris-phosphate (IP3) in rat aortic smooth
muscle cells [20]. The regulation of calmodulin (CM)
function by O2￿−/hydrogen peroxide oxidation of specific
methionine residues is now well-documented [21]. The
oxidation of methionine residues at positions 144 and 145 of
CM is involved in down regulation of plasma membrane
(PM) Ca2+ ATPase activity [22]. It has also been reported
from the same laboratory that methionine sulfoxide reduc-
tase can act reductively to restore the ability of oxidized CM
to regulate PM–Ca2+ ATPase [23]. These results indicate that
O2￿−/hydrogen peroxide functions as part of the controlled
regulation of the CM–PM–Ca2+ ATPase complex.
The regulated prooxidant formation of the O2￿−/H2O2
second messenger system is essential for the normal physio-
logical function of the metabolome. The normally func-
tioning metabolome is the expression of a dynamic equilib-
rium comprised of thousands of anabolic and catabolic
reactions, which are finely tuned by signaling systems.
There is still much to be learnt about the up/down regulation
of these messenger systems. The concept that O2￿−/H2O2
causes random macromolecular damage should be discussed
according to the specific cellular environment. Thus, the
administration of antioxidants to quench the inferred toxicity
of these compounds as a therapy for age associated diseases
should be subjected to serious evaluation and needs to be
supported by results from animal models and clinical trials
[24].
Inhibition of apoptosis
Recent findings have demonstrated that a mild increase in
intracellular superoxide inhibited apoptosis in tumor cells,
irrespective of the trigger [25]. The discovery of the death
inhibitory activity of intracellular O2￿− has challenged the
dogmatic view that ROS are deleterious to cell growth and
survival. It appears that a permissive intracellular environ-
ment for apoptotic signaling is a function of a tight balance
between intracellular O2￿− and H2O2, and that a decrease in
intracellular O2￿− or a reciprocal increase in H2O2 facilitates
apoptotic execution [26]. Earlier data implicated Rac-
dependent increase in intracellular O2￿− in the mitogenic
signaling that is induced upon the activation of Ras [27].
As shown by Pervaiz et al., expression of a constitutively
active form of Rac1 in human melanoma cells (M14)
resulted in a mild increase in intracellular O2￿− with a con-
comitant decrease in the sensitivity of tumor cells to apop-
tosis [28].
Regulation of protein activity and protein turnover
One of the established effects of O2￿− in signaling is the
activation of the ras/rac-Raf1-MAPK pathway [29]. Angio-
tensin II (ANG II) induces O2￿− generation in endothelial
cells via the ubiquitous NAD(P)H oxidase. This O2￿− then
activates the Raf-1-MAPK pathway, leading to altered gene
expression. ANG II has also been shown to stimulate O2￿−
production in the central nervous system to increase vaso-
pressin secretion and sympathetic outflow. This was con-
firmed in vivo as adenoviral vector-mediated expression of
SOD (AdSOD) in mice blocked both ANG II-induced O2￿−
generation and changes in blood pressure, heart rate, and
drinking behavior.
Huang et al. recently demonstrated that ERK activation
induced by PPAR-γ agonists was blocked by a SOD mimetic
and induced by an O2￿−-generating system, representing
another example that O2￿− affecting protein activity [6].
Moreover, as previously described, O2￿− can activate nuclear
transcription factor NFκB [8].
Obviously, protein activation is an important function of
O2￿−. Conventionally, protein modifications by ROS and
reactive nitrogen species (RNS) are considered as random
and highly undesirable, leading to protein malfunction.
In turn, these modified proteins must be removed by
proteasome-catalyzed degradation. However, contrary to
this concept, current viewpoints suggest that NO/peroxyni-
trite and O2￿−/H2O2 do not simply randomly damage proteins,
instead, they play important roles in the regulated proteol-
ysis and homeostasis of proteins. One example of protein
degradation promoted by O2￿− as mentioned above is the
regulation of calmodulin activity [21, 22].
In addition, O2￿− continually formed in small amounts
during the oxidation of hemoglobin (Hb) to met Hb in the
order of a steady state amount of 1–3%. The met Hb formed
is continually reduced back to Hb by erythrocyte met Hb
reductase to maintain oxygen homeostasis [18]. It suggests
that the production of superoxide anion related to the body’s
oxygen supply.
Physiological Functions of Uncoupling Proteins
The UCPs are a family of mitochondrial anion-carrier
proteins that are located on the inner mitochondrial
membrane. The UCP superfamily comprises integral mem-
brane proteins that share structural and functional similarities.
A common feature is a tripartite structure, with three repeats
of ~100 amino acids, each containing two hydrophobicZ. Wu et al.
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stretches that correspond to transmembrane alpha helices.
The two transmembrane helices in each repeat are linked by
a long hydrophilic loop, which is orientated towards the
matrix side of the membrane, and the amino and carboxyl
termini of UCP extend into the intermembrane space. Inter-
estingly, anion carriers and channel proteins most frequently
rely on the formation of alpha-helical stretches with 12
membrane-spanning regions, and the functional unit of
UCPs is a homodimer formed by two identical subunits that
contain 12 transmembrane helices. Therefore, although
UCP4 and BMCP1 are divergent in amino acid sequence
compared with UCP1, they share a common protein struc-
ture with UCP1–3, which underlies functional anion-carrier
proteins.
Mitochondrial uncoupling mediated by UCP1 is classically
associated with non-shivering thermogenesis by brown fat.
Recent evidence indicates that UCP family proteins are also
present in selected neurons. Notably, UCP4 and BMCP1
(also known as UCP5) have been shown to be highly
expressed in the central nervous system. Unlike UCP1, these
proteins (UCP2, UCP4 and BMCP1/UCP5) are not constitu-
tive uncouplers and are not crucial for the non-shivering
thermogenesis. However, they can be activated by free
radicals and free fatty acids, and their activity has a profound
influence on neuronal functions [30]. Except for UCP1, the
precise physiological functions of UCPs have not yet been
established. Following are several viewpoints about the
physiological functions of UCPs.
Regulation of ROS production
UCPs are thought to be responsible for an inducible, mild
uncoupling of mitochondria that may be able to prevent
excessive mitochondrial ROS production [3, 31]. A lot of
articles support this view, but it is hard to tell whether
regulation of ROS production is the main function of UCPs
or just the side effect of the main function.
Transportation of mitochondrial substrates
UCP3 expressed in glycolytic muscle fibres may be a
passive pyruvate transporter ensuring equilibrium between
glycolysis and oxidative phosphorylation. Induction of
UCP2 expression by glutamine strengthens the hypothesis
that newly discovered UCPs could act to determine the
choice of mitochondrial substrate [31].
Calcium regulation
Mitochondria have evolved as important cytosolic calcium
buffers. Since calcium cannot be metabolized like other
second-messenger molecules, intracellular calcium must be
tightly regulated to maintain homeostasis. UCP2 and UCP3
were reported to be fundamentally involved in mito-
chondrial Ca2+ uniport, the process that represents the main
pathway sequestrating Ca2+ into the mitochondrial matrix
[32]. UCP4, a neuronal UCP, was also reported to regulate
cellular Ca2+ homeostasis [33]. As mitochondria are enriched
in presynaptic terminals, and the calcium milieu of axon
terminals is important in vesicle traffic, fusion, release and
recycling, regulation of presynaptic calcium concentrations
by UCPs is expected to affect neurotransmission directly
[30]. Our study shows that UCP2 and UCP4 have an impor-
tant impact on mitochondrial calcium concentration of nerve
cells, suggesting that their abnormal expression may be
involved in the pathogenesis of AD [34].
Thermogenesis in microenvironments
CNS areas rich in UCPs (such as the hypothalamus) have
a higher local temperature than areas relatively devoid of
UCPs (for example, the striatum and thalamus, which have a
2.7% reduction compared with the hypothalamus), despite
steady core body temperature. Recent evidence indicates
that temperature gradients created by neuronal UCPs
enhance the migration of chemical signals from a cell source
to high-affinity receptors on cells for the signal, especially in
brain regions where there are mismatches in innervation and
receptor localization [35].
In short, by regulating mitochondrial biogenesis, calcium
flux, free radical production and local temperature, neuronal
UCPs can directly influence neurotransmission, synaptic
plasticity and neurodegenerative processes. Insights into the
regulation and function of these proteins offer unsuspected
avenues for a better understanding of synaptic transmission
and neurodegeneration [30].
The Roles of O2￿− and Uncoupling Proteins in the
Pathogenesis of Alzheimer’s Disease
Alzheimer’s disease affects almost 2% of the population
in industrialized countries and the risk is significantly
increased in individuals of more than 70 years of age. It is
characterized by neurofibrillary tangle formation in neuronal
perikarya and extracellular deposits of amyloid-β protein
[36]. Unfortunately, up to date we still have no effective cure
for this disease. The studies over the past one hundred years
haven’t given a complete answer for its etiology and patho-
genesis. Therefore, according to new research data to
explore the etiology and pathogenesis of AD from different
perspectives is necessary.
The roles of O2￿− in the pathogenesis of AD
There is extensive literature supporting a role of oxidative
damage in the pathogenesis of AD and oxidative damage
probably contribute causally to AD-related pathology [2].
Oxidative damage occurs early in the AD brain, before the
onset of significant plaque pathology. Oxidative damage
also precedes Aβ deposition in transgenic APP mice, with
up-regulation of genes relating to mitochondrial metabolismSuperoxide, UCPs and Alzheimer’s Disease
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and apoptosis occurring even earlier and co-localizing with
the neurons undergoing oxidative damage. In a transgenic
APP-mutant mouse, hemizygous deficiency of the mito-
chondrial antioxidant enzyme MnSOD markedly increased
brain Aβ levels and plaque deposition [37]. O2￿− is the
precursor of many other ROS, thus its production may
initiate the oxidative damage seen in AD brain.
Several cell signaling pathways linking oxidative stress
and AD pathology have been uncovered recently. Specifi-
cally, oxidative stress may activate signaling pathways that
alter APP or tau processing. For example, oxidative stress
increases the expression of β-secretase through activation of
c-Jun amino-terminal kinase and p38 MAPK, and increases
aberrant tau phosphorylation by activation of glycogen
synthase kinase 3 [38]. Oxidant-induced inactivation of
critical molecules may also be important. In a proteomic
study, the prolyl isomerase PIN1 was found to be parti-
cularly sensitive to oxidative damage. PIN1 catalyses pro-
tein conformational changes that affect both APP and tau
processing. Knockout of Pin1 increases amyloidogenic APP
processing and intracellular Aβ levels in mice [39]. PIN1-
knockout mice also exhibit tau hyperphosphorylation, motor
and behavioural deficits, and neuronal degeneration [40].
Therefore, oxidative stress may lead to AD-related patho-
logical changes by inactivating PIN1.
AD was associated with significantly increased expres-
sion of the p53 pro-apoptosis gene, all 3 isoforms of nitric
oxide synthase (NOS 1-3), and NOX 1 and NOX 3, begin-
ning early in the course of disease. Activation of cyto-
protective mechanisms in AD brains is limited since the
expression of uncoupling protein 2, 4, and 5, and PPAR
alpha and delta genes is significantly reduced, whereas
PPAR-gamma expression is selectively increased. The
results demonstrate that AD is associated with early and
striking increases in the molecular indices of oxidative
stress. The simultaneous reductions in cyto-protective
mechanisms (UCP and PPAR), could allow oxidative injury
to go unchecked and persist or increase over time. Adopting
strategies to reduce the effects of NOS and NOX activities,
and improve the actions of UCPs and PPARs may help in
the treatment of AD [41].
Notably, mitochondrion is the bridge to link together O2￿−,
UCPs and AD. Converging evidences suggest that most of
the proteins implicated in AD pathogenesis have direct
physical involvement with mitochondria or mitochondrial
proteins. APP has been found to have a dual endoplasmic
reticulum/mitochondrial-targeting sequence, and in cells
and transgenic mice overexpressing APP it clogged the
mitochondrial protein importation machinery, causing mito-
chondrial dysfunction and impaired energy metabolism [42].
Aβ binds to a mitochondrial-matrix protein termed Aβ-
binding alcohol dehydrogenase (ABAD). Blocking the
interaction of Aβ and ABAD with a ‘decoy peptide’
suppressed Aβ-induced apoptosis and free-radical genera-
tion in neurons. Conversely, overexpression of ABAD in
transgenic APP-mutant mice exaggerated neuronal oxida-
tive stress and impaired memory [43]. Two other groups
have also reported that Aβ interacts with mitochondria,
inhibiting cytochrome oxidase activity and increasing free-
radical generation [44]. Aβ also inhibits α-ketoglutarate
dehydrogenase activity in isolated mitochondria, and
deficiency of α-ketoglutarate dehydrogenase and cyto-
chrome oxidase activities has previously been observed in
the brain and other tissues in AD [45]. Aβ also interacts
with the serine protease HTRA2 (also known as OMI) [46].
Presenilin and all the other components of the γ-secretase
complex have also been localized to mitochondria, where
they form an active γ-secretase complex [47].
It should be noted that most cells possess enzymatic
systems that are capable of producing O2￿−, whereas to date
no cellular system is known to exclusively generate H2O2.
In most cases, the first reaction of O2 is the one-electron
reduction O2￿−. Although many biological effects have been
ascribed to H2O2 and have been extensively discussed
elsewhere, the insight starts to emerge that O2￿− may be a
more important mediator of cellular effects [12].
The roles of UCPs in the pathogenesis of AD
As mentioned above, once the expression levels of UCP
2, 4, 5 were significantly decreased, the ability of neurons
from AD brain to be protected from oxidative stress damage
was impaired. The impairment of the cell self-protection
mechanism (UCPs and PPARs) makes it possible for the
oxidative damage to persist unrestrictedly, even exacerbate
over time.
Intriguingly, O2￿− themselves can induce the expression of
UCPs, including UCP2 and UCP4 [34], and activate proton
transport through UCP1–3 [48]. Moreover, products of
oxidative stress, such as 4-hydroxy-2-nonenal, may also
regulate mitochondrial uncoupling [49]. Therefore, ROS-
induced uncoupling might act as a simple feedback mecha-
nism to limit the extent of oxidative cell damage, which
could lead to protection against neurodegenerative diseases
and ageing.
Tangles and plaques are found predominantly in areas of
AD brain that regulate learning, memory and emotional
behaviours, including the hippocampus, cortex, basal
forebrain and brain stem. Interestingly, these brain regions
also express neuronal UCPs. Although there are no studies
directly linking neuronal uncoupling activity to Alzheimer’s
disease, neuronal UCPs might regulate many of the patho-
genic mechanisms that lead to neuronal degeneration, such
as increased oxidative damage, perturbed cellular calcium
homeostasis, impaired energy metabolism and synaptic
dysfunction [36]. Indeed, UCP4 modulates neuronal energy
metabolism by increasing glucose uptake and shifting theZ. Wu et al.
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mode of ATP production from mitochondrial respiration to
glycolysis, thereby maintaining cellular ATP levels [50], and
abnormalities in glucose regulation and insulin resistance
are risk factors for Alzheimer’s disease [51]. Furthermore,
dietary restriction, which protects neurons from dysfunction
and death in models of Alzheimer’s disease [36], also
enhances UCP4 expression in the cortex and hippocampus
[52]. Our study shows that UCP2 and UCP4 modulate
mitochondrial calcium concentration of nerve cells, and can
be regulated by O2￿−, suggesting that this dysfunction of
mitochondrial calcium may be involved in the pathogenesis
of AD [34].
Concluding Remarks
In summary, O2￿− is an oxygen free radical with important
physiological functions in  vivo; UCPs are proteins with
important physiological functions in  vivo. O2￿− is like a
sharp double-edged sword, on the one hand, activating gene
transcription, promoting cell growth and proliferation and
inhibiting apoptosis, on the other hand, leading to oxidative
stress, causing apoptosis. Neuronal UCPs can resist oxida-
tive stress or maintain the calcium regulation capability of
mitochondria to play a role in preventing the neuro-
degeneration of Alzheimer’s disease. Simultaneous dis-
orders of O2￿− and uncoupling proteins create the conditions
for the neuronal oxidative damage. Sustained oxidative
damage can further cause neuronal apoptosis and eventually,
extended neuronal death, leading to exacerbations of
Alzheimer’s disease. Block oxidative damage and balance
of free radicals generation may inhibit neuronal apoptosis
and eventually prevent and cure Alzheimer’s disease.
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